Neuromorphic Cardiac Pacing System with Adaptive Electrode Configurations

A next-generation cardiac pacing system that utilizes a neuromorphic processor to learn and adapt to a patient's cardiac rhythms, delivering personalized pacing stimuli through a multi-electrode array.

The original patent addresses the limitation of selecting one or more electrode combinations from a plurality of electrodes. However, this approach is limited by its inability to adapt to changing cardiac rhythms and patient conditions. The new inventive concept solves this problem by introducing a neuromorphic processor that can learn and adapt to a patient's cardiac rhythms in real-time, enabling more effective and personalized pacing.

The neuromorphic cardiac pacing system consists of a wearable sensor that monitors a patient's cardiac rhythms and physical activity, a cloud-based database that stores and analyzes cardiac rhythm data from a plurality of patients, and a processor that uses machine learning algorithms to analyze the data and develop personalized pacing protocols. The system adjusts pacing parameters in real-time based on the monitored cardiac rhythms and physical activity, and can predict cardiac arrhythmias using deep learning algorithms.

The new inventive concept introduces the use of neuromorphic processing, machine learning algorithms, and cloud-based data analysis to enable real-time adaptation to changing cardiac rhythms and patient conditions. This represents a significant departure from the original patent's fixed electrode selection approach, and provides a more effective and personalized pacing solution.

Alternative embodiments of the inventive concept could include the use of different types of sensors, such as implantable sensors or mobile devices, to monitor cardiac rhythms and physical activity. Additionally, the system could be integrated with other medical devices, such as pacemakers or implantable cardioverter-defibrillators, to provide a more comprehensive cardiac care solution.

The neuromorphic cardiac pacing system has significant commercial potential in the cardiac care industry, particularly in the areas of personalized medicine and remote patient monitoring. The system could be marketed to hospitals, clinics, and medical device manufacturers, and could potentially disrupt the existing cardiac pacing market by providing a more effective and adaptive solution.